Hydrogel Rectal Spacer: Radiopaque vs. Non-radiopaque
Richard G. Stock, MD, explores the role of rectal spacers in reducing gastrointestinal toxicity during prostate cancer radiotherapy.
Read MoreSelect Page
Posted by Richard G. Stock, MD | Mar 2025
Richard G. Stock, MD, explores the role of rectal spacers in reducing gastrointestinal toxicity during prostate cancer radiotherapy.
Read MorePosted by Quoc-Dien Trinh, MD, MBA | Mar 2025
Quoc-Dien Trinh, MD, MBA, discusses community outreach and efforts to address racial disparities in prostate cancer outcomes.
Read MorePosted by Alexandra Drakaki, MD, PhD | Mar 2025
Alexandra Drakaki, MD, PhD, explores circulating tumor DNA in bladder cancer, highlighting its potential as a biomarker.
Read MorePosted by Jamie Jacobs, PhD | Mar 2025
Jamie Jacobs, PhD, presents a talk on the PROWESS study for Black and Latino men with metastatic prostate cancer undergoing ADT.
Read MorePosted by Gopalkumar Iyer, MD | Mar 2025
Gopalkumar Iyer, MD, explores the role of genomic alterations in predicting response to neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Read More